Improving Care for People Living With Dementia and Diabetes: Applying the Human-Centered Design Process to Continuous Glucose Monitoring.
April SavoyRichard J HoldenMary de GrootDaniel O ClarkGreg A SachsDavid C KlonoffMichael WeinerPublished in: Journal of diabetes science and technology (2022)
People with Alzheimer's disease or related dementias and diabetes mellitus (ADRD-DM) are at high risk for hypoglycemic events. Their cognitive impairment and psychosocial situation often hinder detection of hypoglycemia. Extending use and benefits of continuous glucose monitoring (CGM) to people with ADRD-DM could improve hypoglycemia detection, inform care, and reduce adverse events. However, cognitive impairment associated with ADRD presents unique challenges for CGM use. This commentary proposes applying the human-centered design process to CGM, investigating design solutions or interventions needed to integrate CGM into the health care of patients with ADRD-DM. With this process, we can identify and inform CGM designs for people with ADRD-DM, broadening CGM access, increasing detection and treatment of the silent threat posed by hypoglycemia.
Keyphrases
- glycemic control
- cognitive impairment
- type diabetes
- healthcare
- endothelial cells
- loop mediated isothermal amplification
- real time pcr
- label free
- palliative care
- weight loss
- induced pluripotent stem cells
- mild cognitive impairment
- quality improvement
- insulin resistance
- cardiovascular disease
- physical activity
- pluripotent stem cells
- mental health
- cognitive decline
- adipose tissue
- health insurance
- affordable care act
- metabolic syndrome
- health information
- drug induced